Trial Outcomes & Findings for The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses (NCT NCT05766787)
NCT ID: NCT05766787
Last Updated: 2024-06-13
Results Overview
Visual acuity (VA) was assessed for each eye individually with study lenses in place using logarithmic of the Minimum Angle of Resolution (logMAR) reading charts. LogMAR values typically range from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.
COMPLETED
NA
190 participants
Week 1 of each lens product worn during the corresponding crossover period
2024-06-13
Participant Flow
Participants were recruited from 15 investigative sites located in the United States.
Of the 190 enrolled, 3 participants were exited prior to randomization as screen failures. Of the 187 randomized, 1 participant was discontinued prior to exposure to the study lenses due to ocular pre-treatment adverse events. This reporting group includes all participants exposed to any study lenses (186).
Unit of analysis: eyes
Participant milestones
| Measure |
LID022821, Then AOHP
Serafilcon A contact lenses worn first, with senofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
|
AOHP, Then LID022821
Senofilcon A contact lenses worn first, with serafilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
|
|---|---|---|
|
First Wear Period, Approximately 7 Days
STARTED
|
94 188
|
92 184
|
|
First Wear Period, Approximately 7 Days
COMPLETED
|
93 186
|
89 178
|
|
First Wear Period, Approximately 7 Days
NOT COMPLETED
|
1 2
|
3 6
|
|
Second Wear Period, Approximately 7 Days
STARTED
|
93 186
|
88 176
|
|
Second Wear Period, Approximately 7 Days
COMPLETED
|
93 186
|
87 174
|
|
Second Wear Period, Approximately 7 Days
NOT COMPLETED
|
0 0
|
1 2
|
Reasons for withdrawal
| Measure |
LID022821, Then AOHP
Serafilcon A contact lenses worn first, with senofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
|
AOHP, Then LID022821
Senofilcon A contact lenses worn first, with serafilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
|
|---|---|---|
|
First Wear Period, Approximately 7 Days
Adverse Event
|
0
|
1
|
|
First Wear Period, Approximately 7 Days
Withdrawal by Subject
|
1
|
2
|
|
Second Wear Period, Approximately 7 Days
Adverse Event
|
0
|
1
|
Baseline Characteristics
The Clinical Performance of Two Reusable Silicone Hydrogel Contact Lenses
Baseline characteristics by cohort
| Measure |
LID022821, Then AOHP
n=94 Participants
Serafilcon A contact lenses worn first, with senofilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
|
AOHP, Then LID022821
n=92 Participants
Senofilcon A contact lenses worn first, with serafilcon A contact lenses worn second, as randomized. Each study lens type was worn bilaterally (in both eyes) for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
|
Total
n=186 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Continuous
|
34.1 years
STANDARD_DEVIATION 8.6 • n=5 Participants
|
33.9 years
STANDARD_DEVIATION 9.0 • n=7 Participants
|
34.0 years
STANDARD_DEVIATION 8.8 • n=5 Participants
|
|
Sex: Female, Male
Female
|
60 Participants
n=5 Participants
|
64 Participants
n=7 Participants
|
124 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
34 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
62 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
White
|
66 Participants
n=5 Participants
|
62 Participants
n=7 Participants
|
128 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Black or African American
|
7 Participants
n=5 Participants
|
9 Participants
n=7 Participants
|
16 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
American Indian or Alaska Native
|
1 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Asian
|
20 Participants
n=5 Participants
|
19 Participants
n=7 Participants
|
39 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Other
|
0 Participants
n=5 Participants
|
1 Participants
n=7 Participants
|
1 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Hispanic or Latino
|
6 Participants
n=5 Participants
|
7 Participants
n=7 Participants
|
13 Participants
n=5 Participants
|
|
Race/Ethnicity, Customized
Not Hispanic or Latino
|
88 Participants
n=5 Participants
|
85 Participants
n=7 Participants
|
173 Participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Week 1 of each lens product worn during the corresponding crossover periodPopulation: Full Analysis Set: All randomized subjects who were exposed to any study lenses evaluated in this study with data at Week 1 visit.
Visual acuity (VA) was assessed for each eye individually with study lenses in place using logarithmic of the Minimum Angle of Resolution (logMAR) reading charts. LogMAR values typically range from -0.3 (20/10 vision on the Snellen chart) to 1 (20/200 vision). A logMAR acuity of 0.0 corresponds to 20/20 Snellen acuity (normal distance visual acuity), with a negative value denoting better than 20/20 visual acuity.
Outcome measures
| Measure |
LID022821
n=362 eyes
Serafilcon A contact lenses worn first or second, as randomized, in both eyes for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
|
AOHP
n=370 eyes
Senofilcon A contact lenses worn first or second, as randomized, in both eyes for approximately 14 days. CLEAR CARE was used for daily cleaning and disinfection.
|
|---|---|---|
|
Least Squares Mean Distance VA With Study Lenses at Week 1
|
-0.11 logMAR
Standard Error 0.005
|
-0.10 logMAR
Standard Error 0.005
|
Adverse Events
Pretreatment
LID022821 - Ocular
LID022821 - Non-Ocular
AOHP - Ocular
AOHP - Non-Ocular
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Clinical Project Lead, Vision Care
Alcon Research, LLC
Results disclosure agreements
- Principal investigator is a sponsor employee Sponsor reserves the right of prior review of any publication or presentation of information related to the study.
- Publication restrictions are in place
Restriction type: OTHER